Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04022382 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual Occlusion
A NA study of Dry Eye, sponsored by John C Meyer, MD.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT04022382: Completed NA study of Dry Eye, sponsored by John C Meyer, MD.
NCT04022382 is a NA study of Dry Eye that has completed, run by John C Meyer, MD. The registered enrollment target is 17 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04022382, a NA study of Dry Eye, has completed, sponsored by John C Meyer, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
A study which participants with mild to moderate dry eye disease will have a punctum of one eye injected with 0.1ml Restylane Defyne and the other eye injected with 0.2ml Restylane Defyne. Participants will be evaluated over four visits.
Primary Outcome
Maximum length of tears absorbed on test strips recorded.
Conditions Studied
Interventions
- DEVICE Restylane Defyne
Study Locations (1)
Kentucky
- The Eye Care Institute - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-07-18 |
| Est. Completion | 2019-08-26 |
| Phase | NA |
What the finished NCT04022382 record still lists
NCT04022382 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which Restylane Defyne is the first listed.
NCT04022382 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT04022382 about?
NCT04022382 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual Occlusion". A study which participants with mild to moderate dry eye disease will have a punctum of one eye injected with 0.1ml Restylane Defyne and the other eye injected with 0.2ml Restylane Defyne. Participants will be evaluated over four visits.
What is the current status of trial NCT04022382?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-07-18. Estimated completion is 2019-08-26.
What conditions does trial NCT04022382 study?
This clinical trial studies the following conditions: Dry Eye.
What interventions are being tested in trial NCT04022382?
The interventions under investigation include: Restylane Defyne (DEVICE).
Who is sponsoring clinical trial NCT04022382?
This trial is sponsored by John C Meyer, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04022382 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04022382's enrollment target sits among peer trials
17 40th of 41 higher than 1 of 41 other Dry Eye trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The THINK Study Incidence of Neurotrophic Keratopathy)
RECRUITING · NA
-
Low Level Light Therapy & Skin Pigmentation
RECRUITING · NA
-
Corneal Epithelial Stem Cells and Dry Eye Disease
COMPLETED · NA
-
Acute Comfort of Lubricant Eye Drops FID 112903
COMPLETED · NA
-
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
COMPLETED · NA
-
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI